Logo | Name | Σ |
---|---|---|
![]() | Le Journal des Entreprises Economy in regions The Journal of Business is ... - The first national network of economic newspapers in the region, present in the heart of major French economic metropolises with editions distributed in 9 regions - daily newsletters - Overlaps and business rankings -B2B events with business newspaper-Events: https://www.linkedin.com/company/le-journal-des-entreprises-events/ Contact subscriptions Azure number: 0810 500 301 Managing Director, Director of Publication: Bruno Dussourt Editorial Director: Philippe Flamand Commercial and development director: Valérie Asti Director Strategy and Diversification: Emmanuelle Bouron Contacts National drafting redacweb@lejournaldesentreprises.com Editorial director: Philippe Flamand - 06 83 28 21 41 Editor -in -chief: Stéphane Vandangeon - 06 … Sectors: | 1511 |
![]() | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 903 |
![]() | Finovam Gestion Finovam Gestion is an investment company approved by the AMF which takes minority participations in innovative SMEs with high growth potential in the high regions of France, Grand-Est and Burgundy Franche Comté. The company, which manages € 100M, invests in companies that have developed innovative offers in the following target sectors: information and communication technologies, health, biotechnologies, agro-resources and ecotechnologies. Finovam Gestion has built solid relations with the Entrepreneurship ecosystem (industrialists, competitiveness centers, incubators, accelerators, universities and research centers) in all targeted sectors in order to be able to source and bring out the best companies. Among our investors (LPS), … | 96 |
![]() | Eurasanté Accélérateur des innovations santé-nutrition, bien vieillir en région Hauts-de-France Eurasanté is a regional economic development agency specialized in the the health sector. It supports the different actors dedicated to health related activities with their research, creation and development projects. The Biology, Nutrition and Health Sector of the Nord-Pas-De-Calais represents 800 companies, and 22 000 employees. Located at the heart of a business park of over 300 hectares gathering 7 hospitals, 50 research laboratories, 145 companies, 4 universities, 5 specialized training institutes, it constitutes a unique business environment in the largest university-hospital campus over Europe. 3 kinds of services are part … Sectors: | 551 |
![]() | Banque Populaire Success is in you. ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- | 1402 |
![]() | France Assureurs Move Society Forward Confidently France Insurers is the use name of the French Insurance Federation which brings together 247 insurance companies representing 99 % of the market for companies governed by the insurance code. Insurance is at the heart of social issues: as such, France Insurers aims to take an active part in the public debate. She is the privileged interlocutor of public authorities, administrations and media on insurance -related subjects, in France and internationally, whether it be questions of prevention, protection, investment or employment. The statistical data which it centralizes and its expertise allow it to support its members … Sectors: | 422 |
![]() | SATT Nord SATT Nord, the innovation partner at the service of your competitiveness SATT Nord, the innovation partner at the service of your competitiveness To boost your competitiveness and your performance: choose innovation! With its direct access to all public research in France, SATT allows you to develop thanks to concrete, useful and quickly marketable technological innovations, You want to consolidate the existing but also to conquer new markets with innovative offers of products or services that anticipate and respond to new trends: our expert team helps you organize better, to find concrete solutions and minimize the risks linked to innovation. To … Tags: SATT Network | 164 |
![]() | Réseau SATT Innovate innovation The SATT network is the association which brings together 13 SATTs, an acceleration companies for technology transfer, whose mission is to simplify and professionalize the transfer of innovations from French academic research to businesses. Created in 2014, the association aims to carry out shared actions in order to increase the efficiency, legibility and visibility of SATTs. Through its action the SATT network, allows: - provide a common technology portfolio to be transferred - Conclude partnerships - Show shared values - Porter a common communication With a single maturation fund in France, SATTs have access to the skills and … Tags: SATT Network | 253 |
![]() | CNRS The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, and Science Sectors: | 3369 |
![]() | Bpifrance Bpifrance account, the public investment bank. Bpifrance, public investment bank, supports businesses, from priming to stock market quotes, from credit to equity. A privileged interlocutor, Bpifrance offers in each region financing or investment solutions adapted to each stage of business life. Bank partner of entrepreneurs, Bpifrance supports them sustainably to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing of SMEs, business creation, international development, investment, creation/transmission, innovation, support, acceleration, and export guarantee Sectors: | 12911 |
![]() | imec Imec is a world-leading R&D and innovation hub in nanoelectronics and digital technologies. At imec, we shape the future by enabling nano- and digital technology innovation that enhances quality of life—together with partners from the industry, government, and academia. Our R&D is built on three core pillars: - a unique 2.5-billion-euro 300mm semiconductor pilot line - over 6,000 colleagues from around the world - an ecosystem of 600+ world-leading industry partners and a global academic network Since 1984, imec quickly made its name as the leading research hub for advanced CMOS scaling and continues to set the course for the … | 999 |
![]() | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3640 |
![]() | PMT Innovation catalyst & amp; BFC business accelerator Competitiveness center since 2005, the PMT catalyzes innovation, has accelerates business and supports the transitions of industries in Burgundy-Franche-Comté. Since 2017, he has been federating thanks to his PMT Health and PMT ASD clusters, the health technology fields on the one hand and aeronautics-space-defense on the other hand, from excellence in microotechnics. It also developed a strong competence in support dedicated to start-ups and innovative companies through its propellant PMT. Microtechnics, health, aeronautics, defense, space, precision mechanics, luxury, innovation, international, labeling, training, medical, burgundy-Franche-Comté, and precision mechanics Sectors: | 330 |
![]() | BFM Business First economic and financial information channel in France. BFM Business TV is the first economic and financial information channel in France. It is distinguished by a programming focused on the search for expertise. Essays around economic news have been established as economic news meetings. "Good Morning Business" for example, offers guests on his set, the latest innovations, editorial and information on background trends. BFM Business TV is also available live on our website as well as an application dedicated to it. Tech, Stock Exchange, Economy, Real Estate, Business, Automobile, and High-Tech Sectors: | 8220 |
![]() | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: | 1648 |